Nakhle Saba, MD, earned his Doctor of Medicine degree from the Lebanese University in Beirut, from which he graduated in 2005. He completed his residency in the Department of Internal Medicine at East Tennessee State University in Johnson City, Tennessee, and Tulane University in New Orleans. In 2008, he started a research track training in hematology and medical oncology at Tulane University, where he closely worked with Laura Levy, PhD, on targeting the kinase PKCβ in b-cell acute lymphoblastic leukemia and diffuse large b-cell lymphoma.
Dr. Saba joined the lab of Adrian Wiestner, MD, PhD, in January 2012 at the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH). His research at the NIH was focused on tumor biology and developing new therapeutic approaches for chronic lymphocytic leukemia and mantle cell lymphoma.
Dr. Saba joined the Tulane faculty in August 2014 as an assistant professor of medicine, where he began a translational program in B-cell malignancies. His research focuses on B-cell malignancies, in particular on CLL and MCL biology, and identifying novel therapeutic targets for these diseases. He treats patients with various hematological malignancies, focusing on lymphoma and B-cell leukemia, as well as performing stem cell transplants.
